EXHIBIT 16.1
MICHAEL GILLESPIE & ASSOCIATES, PLLC
CERTIFIED PUBLIC ACCOUNTANTS
10544 ALTON AVE NE
SEATTLE, WA 98125
206.353.5736
Exhibit 16.1
September 8, 2021
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Goldenwell Biotech, Inc.
Dear Sirs/Madams:
The undersigned Michael Gillespie & Associates, PLLC previously acted as independent accountants of Goldenwell Biotech, Inc. We are no longer acting as independent accountants to the Company.
This letter will confirm that we have read Item 4.01 included in the Form 8-K dated September 8, 2021 of Goldenwell Biotech, Inc. to be filed with the Securities and Exchange Commission and are in agreement with the statements related to our firm.
We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 8-K.
Very truly,
/S/ MICHAEL GILLESPIE & ASSOCIATES, PLLC